Concepedia

Jonathan Bard

JB

54

Publications

5.5K

Citations

34

H-Index

1984

Active since

Affiliations

CHDI Foundation(Current)

Princeton University

Synaptic Research (United States)

Albany Molecular Research (United States)

Pearl River Community College

Jonathan Bard is an author at CHDI Foundation specializing in medicine, pharmacology, and molecular pharmacology.

ORCID

Top concepts

Publications per year

1984–2023

54

Publications

54

Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery

Mei-Chu Lo, Ann Aulabaugh, Guixian Jin et al. · Analytical Biochemistry · 2004 · 675 citations

, , +11

Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.

Jonathan Bard, J M Zgombick, Nika Adham et al. · Journal of Biological Chemistry · 1993 · 526 citations · Full text

, , +16

Cloning and Functional Expression of a Human Y4 Subtype Receptor for Pancreatic Polypeptide, Neuropeptide Y, and Peptide YY

Jonathan Bard, Mary W. Walker, Theresa A. Branchek et al. · Journal of Biological Chemistry · 1995 · 372 citations · Full text

The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.

Carlos Forray, Jonathan Bard, J. M. WETZEL et al. · Molecular Pharmacology · 1994 · 349 citations

A receptor autoradiographic and <i>in situ</i> hybridization analysis of the distribution of the 5‐ht<sub>7</sub> receptor in rat brain

Eric L. Gustafson, Margaret M. Durkin, Jonathan Bard et al. · British Journal of Pharmacology · 1996 · 291 citations · Full text

Rows per page

1–5 of 54